The financials
Bio-Techne by the numbers
Bio-Techne (TECH) reported revenue of $311M in Q3 2026 (quarter ended March 31, 2026), down 1.5% from the same quarter a year earlier. That came with a gross margin of 67% and net income of $51M (16% of revenue). For the full year FY2025, revenue was $1.22B (+5.2% year on year) and net income $73M. Its largest region in 2026-Q1 was US at $167M, 54% of the disclosed total, just ahead of EMEA Excluding UK at 24%.
| Income statement | Q3 2026 | Q3 2025 | Change |
|---|---|---|---|
| Revenue | $311M | $316M | −1.5% |
| Gross profit | $208M | $215M | −2.9% |
| Operating income | $75M | $39M | +95% |
| Net income | $51M | $23M | +126% |
| Diluted EPS | $0.32 | $0.14 | +129% |
| Geographic | Revenue | Share |
|---|---|---|
| US | $167M | 54% |
| EMEA Excluding UK | $73M | 24% |
| CN | $26M | 8.4% |
| APAC Excluding Greater China | $22M | 7.0% |
| GB | $15M | 4.8% |
| Rest Of World | $7.8M | 2.5% |
Business Segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Q1 2026Total $311.4M (+5.3%)
GB grew +16% year on yearRest Of World -15% year on year
Segment Latestquarter on quarteryear on year
- US$167.5M$167.5MQoQ +14%year on year -7.9%+14%-7.9%
- EMEA Excluding UK$73.4M$73.4MQoQ -2.5%year on year +10%-2.5%+10%
- CN$26.0M$26.0MQoQ -1.3%year on year +6.2%-1.3%+6.2%
- APAC Excluding Greater China$21.8M$21.8MQoQ -4.1%year on year +2.7%-4.1%+2.7%
- GB$14.9M$14.9MQoQ +8.5%year on year +16%+8.5%+16%
- Rest Of World$7.8M$7.8MQoQ -30%year on year -15%-30%-15%